185 related articles for article (PubMed ID: 22960427)
1. All-cause and liver-related mortality in hepatitis C infected drug users followed for 33 years: a controlled study.
Kielland KB; Skaug K; Amundsen EJ; Dalgard O
J Hepatol; 2013 Jan; 58(1):31-7. PubMed ID: 22960427
[TBL] [Abstract][Full Text] [Related]
2. Liver fibrosis progression at autopsy in injecting drug users infected by hepatitis C: a longitudinal long-term cohort study.
Kielland KB; Delaveris GJ; Rogde S; Eide TJ; Amundsen EJ; Dalgard O
J Hepatol; 2014 Feb; 60(2):260-6. PubMed ID: 24096048
[TBL] [Abstract][Full Text] [Related]
3. Long-term follow-up among Danish transfusion recipients identified in the national hepatitis C lookback.
Just SA; Grau K; Georgsen J; Weis N; Cowan S; Groenbaek K; Krarup H; Christensen PB;
Transfusion; 2012 Mar; 52(3):582-8. PubMed ID: 21883266
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C virus seromarkers and subsequent risk of hepatocellular carcinoma: long-term predictors from a community-based cohort study.
Lee MH; Yang HI; Lu SN; Jen CL; Yeh SH; Liu CJ; Chen PJ; You SL; Wang LY; Chen WJ; Chen CJ
J Clin Oncol; 2010 Oct; 28(30):4587-93. PubMed ID: 20855826
[TBL] [Abstract][Full Text] [Related]
5. Assessment of long-term outcomes of community-acquired hepatitis C infection in a cohort with sera stored from 1971 to 1975.
Rodger AJ; Roberts S; Lanigan A; Bowden S; Brown T; Crofts N
Hepatology; 2000 Sep; 32(3):582-7. PubMed ID: 10960453
[TBL] [Abstract][Full Text] [Related]
6. Impact of hepatitis C virus infection on all-cause and liver-related mortality in a large community-based cohort of inner city residents.
Grebely J; Raffa JD; Lai C; Kerr T; Fischer B; Krajden M; Dore GJ; Tyndall MW
J Viral Hepat; 2011 Jan; 18(1):32-41. PubMed ID: 20196806
[TBL] [Abstract][Full Text] [Related]
7. Cause of death in individuals with chronic HBV and/or HCV infection, a nationwide community-based register study.
Duberg AS; Törner A; Davidsdóttir L; Aleman S; Blaxhult A; Svensson A; Hultcrantz R; Bäck E; Ekdahl K
J Viral Hepat; 2008 Jul; 15(7):538-50. PubMed ID: 18397223
[TBL] [Abstract][Full Text] [Related]
8. Trends in mortality after diagnosis of hepatitis B or C infection: 1992-2006.
Walter SR; Thein HH; Amin J; Gidding HF; Ward K; Law MG; George J; Dore GJ
J Hepatol; 2011 May; 54(5):879-86. PubMed ID: 21145812
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C and hepatitis B-related mortality in Spain.
García-Fulgueiras A; García-Pina R; Morant C; García-Ortuzar V; Génova R; Alvarez E
Eur J Gastroenterol Hepatol; 2009 Aug; 21(8):895-901. PubMed ID: 19357523
[TBL] [Abstract][Full Text] [Related]
10. Mortality in patients with chronic and cleared hepatitis C viral infection: a nationwide cohort study.
Omland LH; Krarup H; Jepsen P; Georgsen J; Harritshøj LH; Riisom K; Jacobsen SE; Schouenborg P; Christensen PB; Sørensen HT; Obel N;
J Hepatol; 2010 Jul; 53(1):36-42. PubMed ID: 20400197
[TBL] [Abstract][Full Text] [Related]
11. All-cause and liver-related mortality in HIV positive subjects compared to the general population: differences by HCV co-infection.
Hernando V; Perez-Cachafeiro S; Lewden C; Gonzalez J; Segura F; Oteo JA; Rubio R; Dalmau D; Moreno S; Amo JD;
J Hepatol; 2012 Oct; 57(4):743-51. PubMed ID: 22709620
[TBL] [Abstract][Full Text] [Related]
12. High incidence of hepatitis C virus reinfection within a cohort of injecting drug users.
Micallef JM; Macdonald V; Jauncey M; Amin J; Rawlinson W; van Beek I; Kaldor JM; White PA; Dore GJ
J Viral Hepat; 2007 Jun; 14(6):413-8. PubMed ID: 17501762
[TBL] [Abstract][Full Text] [Related]
13. No impact of hepatitis C virus infection on mortality among drug users during the first decade after seroconversion.
Grady B; van den Berg C; van der Helm J; Schinkel J; Coutinho R; Krol A; Prins M
Clin Gastroenterol Hepatol; 2011 Sep; 9(9):786-792.e1. PubMed ID: 21699803
[TBL] [Abstract][Full Text] [Related]
14. Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients.
Fattovich G; Pantalena M; Zagni I; Realdi G; Schalm SW; Christensen E;
Am J Gastroenterol; 2002 Nov; 97(11):2886-95. PubMed ID: 12425564
[TBL] [Abstract][Full Text] [Related]
15. The increasing mortality burden of liver disease among opioid-dependent people: cohort study.
Gibson A; Randall D; Degenhardt L
Addiction; 2011 Dec; 106(12):2186-92. PubMed ID: 21749525
[TBL] [Abstract][Full Text] [Related]
16. Predictors of mortality among injecting and non-injecting HIV-negative drug users in northern Thailand.
Quan VM; Vongchak T; Jittiwutikarn J; Kawichai S; Srirak N; Wiboonnatakul K; Razak MH; Suriyanon V; Celentano DD
Addiction; 2007 Mar; 102(3):441-6. PubMed ID: 17298652
[TBL] [Abstract][Full Text] [Related]
17. Mortality in HIV-infected injection drug users with active vs cleared hepatitis C virus-infection: a population-based cohort study.
Omland LH; Jepsen P; Weis N; Christensen PB; Laursen AL; Nielsen H; Krarup H; Sørensen HT; Obel N
J Viral Hepat; 2010 Apr; 17(4):261-8. PubMed ID: 19709359
[TBL] [Abstract][Full Text] [Related]
18. Prognosis of chronic hepatitis C: results of a large, prospective cohort study.
Niederau C; Lange S; Heintges T; Erhardt A; Buschkamp M; Hürter D; Nawrocki M; Kruska L; Hensel F; Petry W; Häussinger D
Hepatology; 1998 Dec; 28(6):1687-95. PubMed ID: 9828236
[TBL] [Abstract][Full Text] [Related]
19. Minimal but significant improvement in survival for non-hepatitis C-related adult liver transplant patients beyond the one-year posttransplant mark.
McCaughan GW; Shackel NA; Strasser SI; Dilworth P; Tang P;
Liver Transpl; 2010 Feb; 16(2):130-7. PubMed ID: 20104480
[TBL] [Abstract][Full Text] [Related]
20. Mortality among human immunodeficiency virus-infected patients with cirrhosis or hepatocellular carcinoma due to hepatitis C virus in French Departments of Internal Medicine/Infectious Diseases, in 1995 and 1997.
Cacoub P; Geffray L; Rosenthal E; Perronne C; Veyssier P; Raguin G;
Clin Infect Dis; 2001 Apr; 32(8):1207-14. PubMed ID: 11283811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
